The Fyn-STAT5 pathway: A new frontier in igE- and igG-mediated mast cell signaling

Frontiers in Immunology

Volumn 3, Issue MAY, 2012, Pages

  Pullen, Nicholas A ^a   Falanga, Yves T ^a   Morales, Johanna K ^a   Ryan, John J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Fyn; IgE; IgG; IL 10; IL 4; Mast cell; Stat5; TGF

Indexed keywords

EID: 84874026418     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00117     Document Type: Review

References (134)

1. Andrews, N. L., Lidke, K. A., Pfeiffer, J. R., Burns, A. R., Wilson, B. S., Oliver, J. M., and Lidke, D. S. (2008). Actin restricts FcepsilonRI diffusion and facilitates antigen-induced receptor immobilization. Nat. Cell Biol. 10, 955-963.
2. Bailey, D. P., Kashyap, M., Bouton, L. A., Murray, P. J., and Ryan, J. J. (2006). Interleukin-10 induces apoptosis in developing mast cells and macrophages. J. Leukoc. Biol. 80, 581-589.
3. Bailey, D. P., Kashyap, M., Mirmonsef, P., Bouton, L. A., Domen, J., Zhu, J., Dessypris, E. N., and Ryan, J. J. (2004). Interleukin-4 elicits apoptosis of developing mast cells via a Stat6-dependent mitochondr- ial pathway. Exp. Hematol. 32,52-59.
4. Barnstein, B. O., Li, G., Wang, Z., Kennedy, S., Chalfant, C., Nakajima, H., Bunting, K. D., and Ryan, J. J. (2006). Stat5 expression is required for IgE-mediated mast cell function. J. Immunol. 177, 3421-3426.
5. Beal, A. M., Ramos-Hernandez, N., Riling, C. R., Nowelsky, E. A., and Oliver, P. M. (2011). TGF-beta induces the expression of the adap- tor Ndfip1 to silence IL-4 produc- tion during iT(reg) cell differentia- tion. Nat. Immunol. 13, 77-85.
6. Benhamou, M., Bonnerot, C., Fridman, W. H., and Daëron, M. (1990). Mol- ecular heterogeneity of murine mast cell Fc gamma receptors. J. Immunol. 144, 3071-3077.
7. Berg, D. J., Kuhn, R., Rajewsky, K., Muller, W., Menon, S., Davidson, N., Grunig, G., and Rennick, D. (1995). Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endo- toxin tolerance. J. Clin. Invest. 96, 2339-2347.
8. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., and Kuchroo, V. K. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238.
9. Bischoff, S. C., Sellge, G., Lorentz, A., Sebald, W., Raab, R., and Manns, M. P. (1999). IL-4 enhances prolifera- tion and mediator release in mature human mast cells. Proc. Natl. Acad. Sci. U.S.A. 96, 8080-8085.
10. Bissonnette, E. Y., Enciso, J. A., and Befus, A. D. (1997). TGF-beta1 inhibits the release of histamine and tumor necrosis factor-alpha from mast cells through an autocrine pathway. Am. J. Respir. Cell Mol. Biol. 16, 275-282.
11. Blobe, G. C., Schiemann, W. P., and Lodish, H. F. (2000). Role of transforming growth factor beta in human disease. N.Engl.J.Med.342, 1350-1358.
12. Bouton, L. A., Ramirez, C. D., Bai- ley, D. P., Yeatman, C. F., Yue, J., Wright, H. V., Domen, J., Rosatao, R. R., Grant, S., Fischer-Stanger, K., and Ryan, J. J. (2004). Costimulation with interleukin-4 and interleukin- 10 induces mast cell apoptosis and cell-cycle arrest: the role of p53 and the mitochondrion. Exp. Hematol. 32, 1137-1145.
13. Brdicka, T., Pavlistová, D., Leo, A., Bruyns, E., Korinek, V., Ange- lisová, P., Scherer, J., Shevchenko, A., Hilgert, I., Cerný, J., Drbal, K., Kuramitsu, Y., Kornacker, B., Horejsí, V., and Schraven, B. (2000). Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiq- uitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. J. Exp. Med. 191, 1591-1604.
14. Brizzi, M. F., Dentelli, P., Rosso, A., Yarden, Y., and Pegoraro, L. (1999). STAT protein recruitment and acti- vation in c-Kit deletion mutants. J. Biol. Chem. 274, 16965-16972.
15. Broide, D. H., Wasserman, S. I., Alvaro-Gracia, J., Zvaifler, N. J., and Firestein, G. S. (1989). Transform- ing growth factor-beta 1 selectively inhibits IL-3-dependent mast cell proliferation without affecting mast cell function or differentiation. J. Immunol. 143, 1591-1597.
16. Brown, M. A., and Hanifin, J. M. (1989). Atopic dermatitis. Curr. Opin. Immunol. 2, 531-534.
17. Crowley, M. T., Costello, P. S., Fitzer- Attas, C. J., Turner, M., Meng, F., Lowell, C., Tybulewicz, V. L., and DeFranco, A. L. (1997). A criti- cal role for Syk in signal trans- duction and phagocytosis medi- ated by Fcgamma receptors on macrophages. J. Exp. Med. 186, 1027-1039.
18. Daëron, M., Malbec, O., Latour, S., Arock, M., and Fridman, W. H. (1995). Regulation of high-affinity IgE receptor-mediated mast cell acti- vation by murine low-affinity IgG receptors. J. Clin. Invest. 95,577-585.
19. Daëron, M., Malbec, O., Latour, S., Bon- nerot, C., Segal, D. M., and Frid- man, W. H. (1993). Distinct intra- cytoplasmic sequences are required for endocytosis and phagocytosis via murine Fc gamma RII in mast cells. Int. Immunol. 5, 1393-1401.
20. Dombrowicz, D., Flamand, V., Miyajima, I., Ravetch, J. V., Galli, S. J., and Kinet, J. P. (1997). Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII- dependent mast cell degranulation and anaphylaxis. Evidence of com- petition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains. J. Clin. Invest. 99, 915-925.
21. Eiseman, E., and Bolen, J. B. (1992). Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 355, 78-80
22. Falanga, Y. T., Chaimowitz, N. S., Charles, N., Finkelman, F. D., Pullen, N. A., Barbour, S., Dholaria, K.,Faber, T., Kolawole, M., Huang, B., Odom,S.,Rivera,J.,Carlyon,J.,Conrad, D. H., Spiegel, S., Oskeritzian, C. A., and Ryan, J. J. (2012). Lyn but not Fyn kinase controls IgG-mediated systemic anaphylaxis. J. Immunol. 188, 4360-4368.
23. Fong, D. C., Malbec, O., Arock, M., Cambier, J. C., Fridman, W. H., and Daeron, M. (1996). Selec- tive in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated Fc gam- maRIIB during negative regulation of IgE-dependent mouse mast cell activation. Immunol. Lett. 54, 83-91.
24. Forward, N. A., Furlong, S. J., Yang, Y., Lin, T. J., and Hoskin, D. W. (2009). Mast cells down-regulate CD4+CD25+ T regulatory cell sup- pressor function via histamine H1 receptor interaction. J. Immunol. 183, 3014-3022.
25. Foster, P. S., Martinez-Moczygemba, M., Huston, D. P., and Corry, D. B. (2002). Interleukins-4, -5, and - 13: emerging therapeutic targets in allergic disease. Pharmacol. Ther. 94, 253-264.
26. Frandji, P., Tkaczyk, C., Oskeritizian, C., David, B., Desaymard, C., and Mecheri, S. (1996). Exogenous and endogenous antigens are differen- tially presented by mast cells to CD4T lymphocytes. Eur. J. Immunol. 26, 2517-2528.
27. Friedbichler, K., Kerenyi, M. A., Kovacic, B., Li, G., Hoelbl, A., Yahiaoui, S., Sexl, V., Müllner, E. W., Fajmann, S., Cerny-Reiterer, S., Valent, P., Beug, H., Gouilleux, F., Bunting, K. D., and Moriggl, R. (2010). Stat5a ser- ine 725 and 779 phosphorylation is a prerequisite for hematopoi- etic transformation. Blood 116, 1548-1558.
28. Galli, S. J., Nakae, S., and Tsai, M. (2005). Mast cells in the develop- ment of adaptive immune responses. Nat. Immunol. 6, 135-142.
29. Galli,S. J.,Tsai,M.,and Piliponsky,A. M. (2008). The development of allergic inflammation. Nature 454, 445-454
30. Gauchat, J.-F., Henchoz, S., Mazzei, G., Aubry, J.-P., Brunner, T., Blasey, H., Life, P., Talabot, D., Flores-Romo, L., Thompson, J., Kishi, K., Butterfield, J., Dahinden, C., and Bonnefoy, J.- Y. (1993). Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365, 340-343.
31. Gazzinelli, R. T., Wysocka, M., Hieny, S., Scharton-Kersten, T., Cheever, A., Kuhn, R., Muller, W., Trinchieri, G., and Sher, A. (1996). In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduc- tion of IL-12, IFN-gamma and TNF- alpha. J. Immunol. 157, 798-805.
32. Gilfillan, A. M., and Rivera, J. (2009). The tyrosine kinase network regu- lating mast cell activation. Immunol. Rev. 228, 149-169.
33. Gillespie, S. R., DeMartino, R. R., Zhu, J., Chong, H. J., Ramirez, C., Shelburne, C. P., Bouton, L. A., Bailey, D. P., Gharse, A., Mirmonsef, P., Odom, S., Gomez, G., Rivera, J., Fischer- Stenger, K., and Ryan, J. J. (2004). IL-10 inhibits Fc epsilon RI expres- sion in mouse mast cells. J. Immunol. 172, 3181-3188.
34. Gomez, G., Gonzalez-Espinosa, C., Odom, S., Baez, G., Cid, M. E., Ryan, J. J., and Rivera, J. (2005a). Impaired FcepsilonRI-dependent gene expres- sion and defective eicosanoid and cytokine production as a conse- quence of Fyn deficiency in mast cells. J. Immunol. 175, 7602-7610.
35. Gomez, G., Ramirez, C. D., Rivera, J., Patel, M., Norozian, F., Wright, H. V., Kashyap, M. V., Barnstein, B. O., Fischer-Stenger, K., Schwartz, L. B., Kepley, C. L., and Ryan, J. J. (2005b). TGF-beta 1 inhibits mast cell Fc epsilon RI expression. J. Immunol. 174, 5987-5993.
36. Grimley, P. M., Dong, F., and Rui, H. (1999). Stat5a and Stat5b: frater- nal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev. 10, 131-157.
37. Hara, M., Ono, K., Hwang, M. W., Iwasaki, A., Okada, M., Nakatani, K., Sasayama, S., and Matsumori, A. (2002). Evidence for a role of mast cells in the evolution to con- gestive heart failure. J. Exp. Med. 195, 375-381.
38. He, Q., Moore, T. T., Eko, F. O., Lyn, D., Ananaba, G. A., Martin, A., Singh, S., James, L., Stiles, J., Black, C. M., and Igietseme, J. U. (2005). Molecular basis for the potency of IL-10-deficient dendritic cells as a highly efficient APC system for acti- vating Th1 response. J. Immunol. 174, 4860-4869.
39. Hernandez-Hansen, V., Smith, A. J., Surviladze, Z., Chigaev, A., Mazel, T., Kalesnikoff, J., Lowell, C. A., Krystal, G., Sklar, L. A., Wilson, B. S., and Oliver, J. M. (2004). Dys- regulated FcepsilonRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cells. J. Immunol. 173, 100-112.
40. Hibbs, M. L., Harder, K. W., Armes, J., Kountouri, N., Quilici, C., Casagranda, F., Dunn,A. R., and Tarlinton, D. M. (2002). Sustained acti- vation of Lyn tyrosine kinase in vivo leads to autoimmunity. J. Exp. Med. 196, 1593-1604.
41. Honda,Z.,Suzuki,T.,Hirose,N.,Aihara, M., Shimizu, T., Nada, S., Okada, M., Ra, C., Morita, Y., and Ito, K. (1997). Roles of C-terminal Src kinase in the initiation and the termination of the high affinity IgE receptor- mediated signaling. J. Biol. Chem. 272, 25753-25760.
42. Howard, M., Muchamuel, T., Andrade, S., and Menon, S. (1993). Inter- leukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177, 1205-1208.
43. Hunter,C.A.,Ellis-Neyes,L.A.,Slifer,T., Kanaly, S., Grunig, G., Fort, M., Ren- nick, D., and Araujo, F. G. (1997). IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158, 3311-3316.
44. Ikeda, K., Nakajima, H., Suzuki, K., Watanabe, N., Kagami, S., and Iwamoto, I. (2005). Stat5a is essen- tial for the proliferation and sur- vival of murine mast cells. Int. Arch. Allergy Immunol. 137(SUPPL. 1), 45-50.
45. Iyer, A. S., Morales, J. L., Huang, W., Ojo, F., Ning, G., Wills, E., Baines, J. D., and August, A. (2011). Absence of Tec family kinases interleukin-2 inducible T cell kinase (Itk) and Bruton's tyrosine kinase (Btk) severely impairs Fc epsilonRI- dependent mast cell responses. J. Biol. Chem. 286, 9503-9513.
46. Jonsson, F., Mancardi, D. A., Kita, Y., Karasuyama, H., Iannascoli, B., Van Rooijen, N., Shimizu, T., Daeron, M., and Bruhns, P. (2011a). Mouse and human neutrophils induce anaphy- laxis. J. Clin. Invest. 121, 1484-1496
47. Jonsson, F., Mancardi, D. A., Zhao, W., Kita, Y., Iannascoli, B., Khun, H., van Rooijen, N., Shimizu, T., Schwartz, L. B., Daeron, M., and Bruhns, P. (2011b). Human FcgammaRIIA induces anaphylactic and allergic reactions. Blood 119, 2533-2544.
48. Kalesnikoff, J., and Galli, S. J. (2008). New developments in mast cell biol- ogy. Nat. Immunol. 9, 1215-1223.
49. Kambayashi,T.,Allenspach,E. J.,Chang, J. T., Zou, T., Shoag, J. E., Reiner, S. L., Caton, A. J., and Koretzky, G. A. (2009). Inducible MHC class II expression by mast cells supports effector and regulatory T cell acti- vation. J. Immunol. 182, 4686-4695
50. Kanbe, N., Kurosawa, M., Nagata, H., Saitoh, H., and Miyachi, Y. (1999). Cord blood-derived human cul- tured mast cells produce transform- ing growth factor beta1. Clin. Exp. Allergy 29, 105-113.
51. Katz, H. R., Raizman, M. B., Gartner, C. S., Scott, H. C., Benson, A. C., and Austen, K. F. (1992). Secretory granule mediator release and gen- eration of oxidative metabolites of arachidonic acid via Fc-IgG recep- tor bridging in mouse mast cells. J. Immunol. 148, 868-871.
52. Kawabuchi, M., Satomi, Y., Takao, T., Shimonishi, Y., Nada, S., Nagai, K., Tarakhovsky, A., and Okada, M. (2000). Transmembrane phospho- protein Cbp regulates the activi- ties of Src-family tyrosine kinases. Nature 404, 999-1003.
53. Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S., Alvarez-Mon, M., Derynck, R., Sporn, M. B., and Fauci, A. S. (1986). Production of transforming growth factor beta by human T lymphocytes and its poten- tial role in the regulation of T cell growth. J. Exp. Med. 163,1037-1050.
54. Kennedy Norton,S.,Barnstein,B.,Brenzovich, J., Bailey, D. P., Kashyap, M., Speiran, K., Ford, J., Conrad, D., Watowich, S., Moralle, M. R., Kepley, C. L., Murray, P. J., and Ryan, J. J. (2008). IL-10 suppresses mast cell IgE receptor expression and signaling in vitro and in vivo. J. Immunol. 180, 2848-2854.
55. Kim, H. J., Zhang, K., Zhang, L., Ross, F. P., Teitelbaum, S. L., and Faccio, R. (2009). The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 106, 2325-2330.
56. Kim, H. M., and Lee, Y. M. (1999). Role of TGF-beta 1 on the IgE- dependent anaphylaxis reaction. J. Immunol. 162, 4960-4965.
57. Kim, M. S., Radinger, M., and Gilfillan, A. M. (2008). The multiple roles of phosphoinositide 3-kinase in mast cell biology. Trends Immunol. 29, 493-501.
58. Kotenko, S. V. (2002). The family of IL- 10-related cytokines and their recep- tors: related, but to what extent? Cytokine Growth Factor Rev. 13, 223-240.
59. Kovarova, M., Wassif, C. A., Odom, S., Liao, K., Porter, F. D., and Rivera, J. (2006). Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness. J. Exp. Med. 203, 1161-1171.
60. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W. (1993). Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274.
61. Kurosaki, T., Gander, I., Wirthmueller, U., and Ravetch, J. V. (1992). The beta subunit of the Fc epsilon RI is associated with the Fc gamma RIII on mast cells. J. Exp. Med. 175, 447-451.
62. Lach-Trifilieff, E., Menear, K., Schweighoffer, E., Tybulewicz, V. L., and Walker, C. (2000). Syk- deficient eosinophils show normal interleukin-5-mediated differentiation, maturation, and survival but no longer respond to FcgammaR activation. Blood 96, 2506-2510.
63. Lee, D. M., Friend, D. S., Gurish, M. F., Benoist, C., Mathis, D., and Brenner, M. B. (2002). Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297, 1689-1692.
64. Lee, Y. K., Mukasa, R., Hatton, R. D., and Weaver, C. T. (2009). Developmental plasticity of Th17 and Treg cells. Curr. Opin. Immunol. 21, 274-280.
65. Letterio, J. J., and Roberts, A. B. (1998). Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16, 137-161.
66. Levi-Schaffer, F., Riesel, N., Soffer, D., Abramsky, O., and Brenner, T. (1991). Mast cell activity in exper- imental allergic encephalomyelitis. Mol. Chem. Neuropathol. 15, 173-184.
67. Lin, T. J., and Befus, A. D. (1997). Dif- ferential regulation of mast cell func- tion by IL-10 and stem cell factor. J. Immunol. 159, 4015-4023.
68. Lindquist, J. A., Simeoni, L., and Schraven, B. (2003). Transmem- brane adapters: attractants for cyto- plasmic effectors. Immunol. Rev. 191, 165-182.
69. Lindstedt, K. A., Wang, Y., Shiota, N., Saarinen, J., Hyytiainen, M., Kokko- nen,J. O.,Keski-Oja,J.,and Kovanen, P. T. (2001). Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chy mase. FASEB J. 15, 1377-1388.
70. Lorentz, A., and Bischoff, S. C. (2001). Regulation of human intestinal mast cellsbystemcellfactorandIL-4. Immunol. Rev. 179, 57-60.
71. Lu, L. F., Lind, E. F., Gondek, D. C., Bennett, K. A., Gleeson, M. W., Pino- Lagos, K., Scott, Z. A., Coyle, A. J., Reed, J. L.,Van Snick, J., Strom, T. B., Zheng,X. X.,and Noelle,R. J. (2006). Mast cells are essential intermedi- aries in regulatory T-cell tolerance. Nature 442, 997-1002.
72. Macey, M. R., Sturgill, J. L., Morales, J. K., Falanga, Y. T., Morales, J., Nor- ton, S. K., Yerram, N., Shim, H., Fernando, J., Gifillan, A. M., Gomez, G., Schwartz,L.,Oskeritzian,C.,Spiegel, S., Conrad, D., and Ryan, J. J. (2010). IL-4 and TGF-beta 1 counterbalance one another while regulating mast cell homeostasis. J. Immunol. 184, 4688-4695.
73. Malaviya, R., Ikeda, T., Ross, E., and Abraham, S. N. (1996). Mast cell modulation of neutrophil influx and bacterial clearance at sites of infec- tion through TNF-alpha. Nature 381, 77-80.
74. Malaviya, R., and Uckun, F. M. (2002). Role of STAT6 in IgE receptor/FcepsilonRI-mediated late phase allergic responses of mast cells. J. Immunol. 168, 421-426.
75. Malbec, O., and Daeron, M. (2007). The mast cell IgG receptors and their roles in tissue inflammation. Immunol. Rev. 217, 206-221.
76. Marshall, J. S., Leal-Berumen, I., Nielsen, L., Glibetic, M., and Jor- dana, M. (1996). Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J. Clin. Invest. 97, 1122-1128.
77. McLachlan, J. B., Hart, J. P., Pizzo, S. V., Shelburne, C. P., Staats, H. F., Gunn, M. D., and Abraham, S. N. (2003). Mast cell-derived tumor necrosis factor induces hypertrophy of drain- ing lymph nodes during infection. Nat. Immunol. 4, 1199-1205.
78. Meade, R., Askenase, P. W., Geba, G. P., Neddermann, K., Jacoby, R. O., and Pasternak, R. D. (1992). Transform- ing growth factor-beta 1 inhibits murine immediate and delayed type hypersensitivity. J. Immunol. 149, 521-528.
79. Mekori, Y. A., and Metcalfe, D. D. (1994). Transforming growth factor- beta prevents stem cell factor- mediated rescue of mast cells from apoptosis after IL-3 deprivation. J. Immunol. 153, 2194-2203.
80. Miller, H. R., Wright, S. H., Knight, P. A., and Thornton, E. M. (1999). A novel function for transform- ing growth factor-beta1: upregula- tion of the expression and the IgE- independent extracellular release of a mucosal mast cell granule- specific beta-chymase, mouse mast cell protease-1. Blood 93,3473-3486
81. Miyajima, I., Dombrowicz, D., Mar- tin, T. R., Ravetch, J. V., Kinet, J. P., and Galli, S. J. (1997). Sys- temic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death asso- ciated with active or IgE- or IgG1- dependent passive anaphylaxis. J. Clin. Invest. 99, 901-914.
82. Moore, K. W., de Waal Malefyt, R., Coffman, R. L., and O'Garra, A. (2001). Interleukin-10 and the interleukin- 10 receptor. Annu. Rev. Immunol. 19, 683-765.
83. Moore, K. W., O'Garra, A., de Waal Malefyt,R.,Vieira,P.,and Mosmann, T. R. (1993). Interleukin-10. Annu. Rev. Immunol. 11, 165-190.
84. Mui, A. L., Wakao, H., O'Farrell, A. M., Harada, N., and Miyajima, A. (1995). Interleukin-3, granulocyte- macrophage colony stimulating fac- tor and interleukin-5 transduce sig- nals through two STAT5 homologs. EMBO J. 14, 1166-1175.
85. Murray, P. J. (2006). Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr. Opin. Pharmacol. 6, 379-386.
86. Nguyen, T. H., and Casale, T. B. (2011). Immune modulation for treatment of allergic disease. Immunol. Rev. 242, 258-271.
87. Ni, S., Zhao, C., Feng, G. S., Paulson, R. F., and Correll, P. H. (2007). A novel Stat3 binding motif in Gab2 mediates transformation of primary hematopoietic cells by the Stk/Ron receptor tyrosine kinase in response to Friend virus infection. Mol. Cell. Biol. 27, 3708-3715.
88. Nimmerjahn, F., and Ravetch, J. V. (2008). Fcgamma receptors as reg- ulators of immune responses. Nat. Rev. Immunol. 8, 34-47.
89. Norozian, F., Kashyap, M., Ramirez, C. D., Patel, N., Kepley, C. L., Barnstein, B. O., and Ryan, J. J. (2006). TGF- beta1 induces mast cell apoptosis. Exp. Hematol. 34, 579-587.
90. Obata, K., Mukai, K., Tsujimura,Y., Ishiwata, K., Kawano, Y., Minegishi, Y., Watanabe, N., and Karasuyama, H. (2007). Basophils are essential ini- tiators of a novel type of chronic allergic inflammation. Blood 110, 913-920.
91. Odom, S., Gomez, G., Kovarova, M., Furumoto, Y., Ryan, J. J., Wright, H. V., Gonzalez-Espinosa, C., Hibbs, M. L., Harder, K. W., and Rivera, J. (2004). Negative regulation of immunoglobulin E-dependent aller- gic responses by Lyn kinase. J. Exp. Med. 199, 1491-1502.
92. Ohtake, H., Ichikawa, N., Okada, M., and Yamashita, T. (2002). Cutting edge: transmembrane phosphoprotein Csk-binding pro- tein/phosphoprotein associated with glycosphingolipid-enriched microdomains as a negative feedback regulator of mast cell signaling through the FcepsilonRI. J. Immunol. 168, 2087-2090.
93. Ono, M., Bolland, S., Tempst, P., and Ravetch, J. V. (1996). Role of the inositol phosphatase SHIP in nega- tive regulation of the immune sys- tem by the receptor Fc(gamma)RIIB. Nature 383, 263-266.
94. Parravicini, V., Gadina, M., Kovarova, M., Odom, S., Gonzalez-Espinosa, C., Furumoto, Y., Saitoh, S., Samelson, L. E., O'Shea, J. J., and Rivera, J. (2002). Fyn kinase initiates complementary signals required for IgE- dependent mast cell degranulation. Nat. Immunol. 3, 741-748.
95. Pawankar, R., Okuda, M., Yssel, H., Okumura, K., and Ra, C. (1997). Nasal mast cells in perennial allergic rhinitis exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE syn- thesis in B cells. J. Clin. Invest. 99, 1492-1499.
96. Pemberton, A. D., Brown, J. K., Wright, S. H., Knight, P. A., and Miller, H. R. (2006). The proteome of mouse mucosal mast cell homologues: the role of transforming growth factor beta1. Proteomics 6, 623-631.
97. Pennington, D. W., Lopez, A. R., Thomas, P. S., Peck, C., and Gold, W. M. (1992). Dog mastocytoma cells produce transforming growth factor beta 1. J. Clin. Invest. 90, 35-41.
98. Piconese, S., Gri, G., Tripodo, C., Musio, S., Gorzanelli, A., Frossi, B., Pedotti, R., Pucillo, C. E., and Colombo, M. P. (2009). Mast cells counteract reg- ulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood 114, 2639-2648.
99. Pribluda, V. S., Pribluda, C., and Met- zger, H. (1994). Transphosphoryla- tion as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation. Proc. Natl. Acad. Sci. U.S.A. 91, 11246-11250.
100. Pullen, N. A., Barnstein, B. O., Falanga, Y. T., Wang, Z., Suzuki, R., Lama Tamang, T. D., Khurana, M. C., Harry, E. A., Draber, P., Bunting, K. D., Mizuno, K., Wilson, B. S., and Ryan, J. J. (2012). Novel mech- anism for FcεRI-mediated signal transducer and activator of tran- scription 5 (STAT5) tyrosine phos- phorylation and the selective influ- ence of STAT5B over mast cell cytokine production. J. Biol. Chem. 287, 2045-2054.
101. Rivera, J., and Gilfillan, A. M. (2006). Molecular regulation of mast cell activation. J. Allergy Clin. Immunol. 117, 1214-1225; quiz 1226.
102. Roers, A., Siewe, L., Strittmatter, E., Deckert, M., Schlüter, D., Stenzel, W., Gruber, A. D., Krieg, T., Rajew- sky, K., and Müller, W. (2004). T cell-specific inactivation of the inter- leukin 10 gene in mice results in enhanced T cell responses but nor- mal innate responses to lipopolysac- charide or skin irritation. J. Exp. Med. 200, 1289-1297.
103. Royer, B., Varadaradjalou, S., Saas, P., Gabiot, A. C., Kantelip, B., Feger, F., Guillosson, J. J., Kantelip, J. P., and Arock, M. (2001a). Autocrine regu- lation of cord blood-derived human mast cell activation by IL-10. J. Allergy Clin. Immunol. 108, 80-86.
104. Royer, B., Varadaradjalou, S., Saas, P., Guillosson, J. J., Kantelip, J. P., and Arock, M. (2001b). Inhibition of IgE-induced activation of human mast cells by IL-10. Clin. Exp. Allergy 31, 694-704.
105. Ryan,J. J.,DeSimone,S.,Klisch,G.,Shelburne,C.,McReynolds,L. J.,Han,K., Kovacs, R., Mirmonsef, P., and Huff, T. F. (1998). IL-4 inhibits mouse mast cell Fc epsilonRI expression through a STAT6-dependent mech- anism. J. Immunol. 161, 6915-6923
106. Ryan, J. J., Huang, H., McReynolds, L. J., Shelburne, C., Hu-Li, J., Huff, T. F., and Paul, W. E. (1997). Stem cell factor activates STAT-5 DNA binding in IL-3-derived bone mar- row mast cells. Exp. Hematol. 25, 357-362.
107. Satterthwaite, A. B., Lowell, C. A., Khan, W. N., Sideras, P., Alt, F. W., and Witte, O. N. (1998). Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways. J. Exp. Med. 188, 833-844.
108. Schindler, C., Levy, D. E., and Decker, T. (2007). JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282, 20059-20063.
109. Secor, V. H., Secor, W. E., Gutekunst, C. A., and Brown, M. A. (2000). Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191, 813-822.
110. Shelburne, C. P., McCoy, M. E., Piekorz, R., Sexl, V., Roh, K. H., Jacobs- Helber, S. M., Gillespie, S. R., Bai- ley, D. P., Mirmonsef, P., Mann, M. N., Kashyap, M., Wright, H. V.,Chong, H. J., Bouton, L. A., Barn- stein, B., Ramirez, C. D., Bunting, K. D., Sawyer, S., Lantz, C. S., and Ryan, J. J. (2003). Stat5 expression is crit- ical for mast cell development and survival. Blood 102, 1290-1297.
111. Sonnenblick, A., Levy, C., and Razin, E. (2005). Immunological trigger of mast cells by monomeric IgE: effect on microphthalmia transcrip- tion factor, STAT3 network of inter- actions. J. Immunol. 175, 1450-1455
112. Speiran, K., Bailey, D. P., Fernando, J., Macey, M., Barnstein, B., Kola- wole, M., Curley, D., Watowich, S. S., Murray, P. J., Oskeritzian, C., and Ryan, J. J. (2009). Endoge- nous suppression of mast cell development and survival by IL- 4 and IL-10. J. Leukoc. Biol. 85, 826-836.
113. Strait, R. T., Morris, S. C., Yang, M., Qu, X. W., and Finkelman, F. D. (2002). Pathways of anaphylaxis in the mouse. J. Allergy Clin. Immunol. 109, 658-668.
114. Suzuki, R., Liu, X., Olivera,A.,Aguiniga, L., Yamashita, Y., Blank, U., Ambud- kar, I., and Rivera, J. (2010). Loss of TRPC1-mediated Ca2+ influx contributes to impaired degran- ulation in Fyn-deficient mouse bone marrow-derived mast cells. J. Leukoc. Biol. 88, 863-875.
115. Takeshita, H., Taniuchi, I., Kato, J., and Watanabe, T. (1998). Abroga- tion of autoimmune disease in Lyn- deficient mice by the mutation of the Btk gene. Int. Immunol. 10, 435-444.
116. Takeuchi, S., Takayama, Y., Ogawa, A., Tamura, K., and Okada, M. (2000). Transmembrane phospho- protein Cbp positively regulates the activity of the carboxyl-terminal Src kinase, Csk. J. Biol. Chem. 275, 29183-29186.
117. Toru, H., Ra, C., Nonoyama, S., Suzuki, K., Yata, J., and Nakahata, T. (1996). Induction of the high-affinity IgE receptor (Fc epsilon RI) on human mast cells by IL-4. Int. Immunol. 8, 1367-1373.
118. Toyota, N., Hashimoto, Y., Matsuo, S., and Iizuka, H. (1995). Transform- ing growth factor beta 1 inhibits IL- 3- and IL-4-dependent mouse con- nective tissue-type mast cell prolif- eration. Arch. Dermatol. Res. 287, 198-201.
119. Trachsel, E., Bootz, F., Silacci, M., Kas- par, M., Kosmehl, H., and Neri, D. (2007). Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthri- tis. Arthritis Res. Ther. 9, R9.
120. Tsujimura, Y., Obata, K., Mukai, K., Shindou,H.,Yoshida,M.,Nishikado, H., Kawano, Y., Minegishi, Y., Shimizu, T., and Karasuyama, H. (2008). Basophils play a piv- otal role in immunoglobulin-G- mediated but not immunoglobulin- E-mediated systemic anaphylaxis. Immunity 28, 581-589.
121. Wiener, Z., Kohalmi, B., Pocza, P., Jeager, J., Tolgyesi, G., Toth, S., Gorbe, E., Papp,Z.,and Falus,A. (2007). TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells. J. Invest. Dermatol. 127, 906-914.
122. Wills-Karp, M., and Finkelman, F. D. (2008). Untangling the complex web of IL-4- and IL-13-mediated signal- ing pathways. Sci. Signal. 1, pe55.
123. Wilson, B. S., Pfeiffer, J. R., Raymond-Stintz, M. A., Lidke, D., Andrews, N., Zhang, J., Yin, W., Steinberg, S., and Oliver,J. M. (2007). Exploring mem- brane domains using native mem- brane sheets and transmission elec- tron microscopy. Methods Mol. Biol. 398, 245-261.
124. Woodman, L., Siddiqui, S., Cruse, G., Sutcliffe, A., Saunders, R., Kaur, D., Bradding, P., and Brightling, C. (2008). Mast cells promote air- way smooth muscle cell differen- tiation via autocrine up-regulation of TGF-beta 1. J. Immunol. 181, 5001-5007.
125. Xiao, W., Nishimoto, H., Hong, H., Kitaura, J., Nunomura, S., Maeda- Yamamoto, M., Kawakami, Y., Lowell, C. A., Ra, C., and Kawakami, T. (2005). Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI. J. Immunol. 175, 6885-6892.
126. Xu, Y., Harder, K. W., Huntington, N. D., Hibbs, M. L., and Tarlinton, D. M. (2005). Lyn tyro- sine kinase: accentuating the posi- tive and the negative. Immunity 22, 9-18.
127. Xue, M., Hsieh, G., Raymond-Stintz, M. A., Pfeiffer, J., Roberts, D., Steinberg, S. L., Oliver, J. M., Prossnitz, E. R., Lidke, D. S., and Wilson, B. S. (2007). Activated N-formyl peptide recep- tor and high-affinity IgE receptor occupy common domains for sig- naling and internalization. Mol. Biol. Cell 18, 1410-1420.
128. Yamashita, Y., Charles, N., Furumoto, Y., Odom, S., Yamashita, T., Gil- fillan, A. M., Constant, S., Bower, M. A., Ryan, J. J., and Rivera, J. (2007). Cutting edge: genetic variation influences Fc epsilonRI- induced mast cell activation and allergic responses. J. Immunol. 179, 740-743.
129. Yang, L., Pang, Y., and Moses, H. L. (2010a). TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol. 31, 220-227.
130. Yang, Z., Zhang, B., Li, D., Lv, M., Huang, C., Shen, G. X., and Huang, B. (2010b). Mast cells mobilize myeloid-derived sup- pressor cells and Treg cells in tumor microenvironment via IL- 17 pathway in murine hepatocarci- noma model. PLoS ONE 5, e8922. doi:10.1371/journal.pone.0008922
131. Yeatman, C. F. II, Jacobs-Helber, S. M., Mirmonsef, P., Gillespie, S. R., Bouton, L. A., Collins, H. A., Sawyer, S. T., Shelburne, C. P., and Ryan, J. J. (2000). Combined stimulation with the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis. J. Exp. Med. 192, 1093-1103.
132. Yoshimura, A., Wakabayashi, Y., and Mori, T. (2010). Cellular and mol- ecular basis for the regulation of inflammation by TGF-beta. J. Biochem. 147, 781-792.
133. Yu, W. M., Hawley, T. S., Hawley, R. G., and Qu, C. K. (2002). Role of the docking protein Gab2 in beta(1)-integrin signaling pathway- mediated hematopoietic cell adhe- sion and migration. Blood 99, 2351-2359.
134. Ziegler, S. F., and Buckner, J. H. (2009). FOXP3 and the regulation of Treg/Th17 differ- entiation. Microbes Infect. 11, 594-598.